| Prasanthi Kandula, | |
|
1244 Boylston St, Chestnut Hill, MA 02467 | |
| (617) 731-1600 | |
| Not Available |
| Full Name | Prasanthi Kandula |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 1244 Boylston St, Chestnut Hill, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225458185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207NS0135X | Dermatology - Procedural Dermatology | 274491 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermphysicians Of New England Llc | 0749522969 | 4 |
| Skincare Physicians Inc | 6800791450 | 14 |
News Archive
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Tulsa CARES is partnering with researchers at the Hudson College of Public Health at the University of Oklahoma Health Sciences Center and the OU-TU School of Community Medicine at the University of Oklahoma to develop and test a novel "food as medicine" intervention for individuals affected by HIV/AIDS.
Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.
A new study over the usefulness of mammography confirms what most people in the breast cancer community already know. Mammograms are one tool in the breast cancer cache: better early detection, widespread awareness and more effective treatments all play a role in reducing deaths from the disease, according to Susan G. Komen for the Cure.
A new approach to predicting which babies will develop type 1 diabetes moves a step closer to routine testing for newborns which could avoid life-threatening complications.
› Verified 2 days ago
| Entity Name | Skincare Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508893843 PECOS PAC ID: 6800791450 Enrollment ID: O20031205000332 |
News Archive
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Tulsa CARES is partnering with researchers at the Hudson College of Public Health at the University of Oklahoma Health Sciences Center and the OU-TU School of Community Medicine at the University of Oklahoma to develop and test a novel "food as medicine" intervention for individuals affected by HIV/AIDS.
Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.
A new study over the usefulness of mammography confirms what most people in the breast cancer community already know. Mammograms are one tool in the breast cancer cache: better early detection, widespread awareness and more effective treatments all play a role in reducing deaths from the disease, according to Susan G. Komen for the Cure.
A new approach to predicting which babies will develop type 1 diabetes moves a step closer to routine testing for newborns which could avoid life-threatening complications.
› Verified 2 days ago
| Entity Name | Dermphysicians Of New England Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558834523 PECOS PAC ID: 0749522969 Enrollment ID: O20190508001468 |
News Archive
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Tulsa CARES is partnering with researchers at the Hudson College of Public Health at the University of Oklahoma Health Sciences Center and the OU-TU School of Community Medicine at the University of Oklahoma to develop and test a novel "food as medicine" intervention for individuals affected by HIV/AIDS.
Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.
A new study over the usefulness of mammography confirms what most people in the breast cancer community already know. Mammograms are one tool in the breast cancer cache: better early detection, widespread awareness and more effective treatments all play a role in reducing deaths from the disease, according to Susan G. Komen for the Cure.
A new approach to predicting which babies will develop type 1 diabetes moves a step closer to routine testing for newborns which could avoid life-threatening complications.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prasanthi Kandula, 1244 Boylston St, Chestnut Hill, MA 02467-2116 Ph: () - | Prasanthi Kandula, 1244 Boylston St, Chestnut Hill, MA 02467 Ph: (617) 731-1600 |
News Archive
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Tulsa CARES is partnering with researchers at the Hudson College of Public Health at the University of Oklahoma Health Sciences Center and the OU-TU School of Community Medicine at the University of Oklahoma to develop and test a novel "food as medicine" intervention for individuals affected by HIV/AIDS.
Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.
A new study over the usefulness of mammography confirms what most people in the breast cancer community already know. Mammograms are one tool in the breast cancer cache: better early detection, widespread awareness and more effective treatments all play a role in reducing deaths from the disease, according to Susan G. Komen for the Cure.
A new approach to predicting which babies will develop type 1 diabetes moves a step closer to routine testing for newborns which could avoid life-threatening complications.
› Verified 2 days ago
Thomas Eugene Rohrer, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467 Phone: 617-731-1600 Fax: 617-731-1601 | |
Jeffrey Michael Sobell, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467 Phone: 617-731-1600 Fax: 617-731-1601 | |
Richard F Horan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 850 Boylston St, Rhumatology Immunology And Allergy Suite 540, Chestnut Hill, MA 02467 Phone: 617-732-9850 | |
Kenneth Alfred Arndt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467 Phone: 617-731-1600 Fax: 617-731-1601 | |
Jeffrey Steven Dover, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1244 Boylston St, Suite 302, Chestnut Hill, MA 02467 Phone: 617-731-1600 Fax: 617-731-1601 | |
Dr. Andrei Metelitsa, M.D., FRCPC Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1244 Boylston St, Chestnut Hill, MA 02467 Phone: 617-731-1600 Fax: 617-731-1601 |